Dana Cohen is a prominent senior manager in the biotech industry, excelling in both private and public companies. With a wealth of knowledge on personalized medicine, diagnostics, therapeutics, drug monitoring, molecular diagnostics technologies, and genetic diseases, Cohen has become an influential business mentor at Tel Aviv and Bar Ilan Universities. She has also proven her capital-raising skills by securing all sorts of local and EU governmental funding amounting to $10 Million, among other notable accomplishments.

Cohen has held many executive positions throughout her career, including CEO at BioMe. YOU. In a capsule, Head of personalized & Predictive Medicine at Zotal, and VP Business Development at Genaphora, among others. Her clinical and medical background in cancer, microbiome applications, HCV, gastroenterology, cardiology, anti-psychotic drugs, and dermatology, alongside her business development and product marketing prowess, has brought her success in the industry.

As the CEO of DiagKnowstics, Cohen has utilized her profound clinical and medical experience to provide cutting-edge diagnostics solutions. She has also been responsible for establishing and managing R&D companies, multi-center clinical sites, and bio-banks. Her expertise in IP/technology commercialization with top pharma and diagnostics companies has helped her excel in the industry.